[Evaluation of urinary factor H excretion in patients with idiopathic membranous nephropathy]

Morito Endo1, Yoshinobu Fuke, Hiroyuki Ohi

  • 1Faculty of Human Health Science, Hachinohe University, Aomori, Japan.

Nihon Jinzo Gakkai Shi
|August 19, 2007
PubMed

Insights

Urinary factor H levels were significantly elevated in patients with idiopathic membranous nephropathy (MN). Treatment led to a marked decline in urinary factor H, correlating with reduced proteinuria and C5b-9 excretion.

Area of Science:

  • Nephrology
  • Immunology
  • Complement System Biology

Context:

  • Idiopathic membranous nephropathy (MN) is a leading cause of nephrotic syndrome in adults.
  • The terminal complement complex (C5b-9) is implicated as a key mediator of proteinuria in MN.
  • Factor H is a critical regulator of complement activation, particularly at the C3 step.

Purpose:

  • To investigate the role of urinary factor H in idiopathic MN.
  • To assess the correlation between urinary factor H levels and disease activity markers.

Summary:

  • Seven patients with biopsy-proven idiopathic MN were monitored for 24 weeks.
  • Urinary factor H, protein, and C5b-9 levels were measured.
  • A significant decrease in urinary factor H was observed post-treatment, paralleling reductions in proteinuria and C5b-9.

Impact:

  • Urinary factor H levels may serve as a significant biomarker for idiopathic MN.
  • Factor H appears to contribute to the regulation of in situ complement activation in MN.
  • Findings suggest potential therapeutic implications targeting the complement system in MN.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...